Geriatric Medicines In-Depth Industrial and Market studies - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Albany, New York, Jan 23,2017

"Geriatric Medicines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2023" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.

Description-

This report on the geriatrics medicines market studies the current and future prospects of the global market. Geriatrics is a branch of medicines concerned with clinical, remedial, preventive, and social aspects of illness usually among people over 65 years of age. In response to the needs and demands of an aging population, demand for geriatric medicines has grown rapidly in last few decades.

Get Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=207169

The elderly patients across the globe face an array of ill health conditions which include co-morbid complexities such as falls, cerebral ageing, and syncope among others. According to the Eurostat the number of people aged 65 tears and above is likely to be 141 million by 2050 globally which is approximately 17%-30% increase in specific population group as compared to 2008 geriatric population. An article published by the Indian Express in June 2014 stated that people aged 60 years and above are likely to reach 323 million mark by 2050. In 2010 approximately 45-50% of the prescriptions were provided to people aged 60 and above and one in three patients took at least 5 drugs or more on a daily basis in United States. In last few decades, geriatric medicines have experienced substantial growth due to which it has now become a prominent part of the American medicines. National Institute on Aging aims to improve health and well-being of older Americans through research and identification of new clinical interventions. In general geriatric medicines market can be segmented in three prominent sub classes

– Table of Content

1. Preface
1.1. Report Description
1.2. Market Segmentation
1.3. Research Methodology

2. Executive Summary
2.1. Global Geriatric Medicines Market, by Geography, 2014 & 2023 (Value %)
2.2. Global Geriatric Medicines Market, by Therapeutic Category, 2014 (US$ Mn)
2.3. Geriatric Medicines Market Snapshot

3. Global Geriatric Medicines Market – Industry Analysis
3.1. Introduction
3.2. Market Drivers
3.2.1. Rise in Chronis Diseases
3.2.2. Increase in Government support
3.3. Restraints
3.3.1. Lack of Patient Participation in Clinical Trials
3.4. Opportunity
3.4.1. Asia Pacific Holds Immense Potential for Geriatric Medicines
3.5. Pipeline Analysis (Phase III Drug Candidate)
3.6. Market Attractiveness Analysis– Geriatric Medicines Market, by Geography (2014) (%)
3.7. Heat Map Analysis, by Key Players, 2014

4. Market Segmentation – By Therapeutic Category
4.1. Introduction
4.2. Global Geriatric Medicines Market Revenue, by Therapeutic Category, 2013–2023 (US$ Mn)
4.3. Global Analgesic Market Revenue, 2013–2023 (US$ Mn)
4.4. Global Antihypertensive Market Revenue, 2013–2023 (US$ Mn)
4.5. Global Statins Market Revenue, 2013–2023 (US$ Mn)
4.6. Global Antidiabetic Market Revenue, 2013–2023 (US$ Mn)
4.7. Global PPI Market Revenue, 2013–2023 (US$ Mn)
4.8. Global Anticoagulant Market Revenue, 2013–2023 (US$ Mn)
4.9. Global Antipsychotic Market Revenue, 2013–2023 (US$ Mn)
4.10. Global Others Market Revenue, 2013–2023 (US$ Mn)

5. Market Segmentation – By Condition
5.1. Introduction
5.2. Global Geriatric Medicines Market Revenue, by Condition, 2013–2023 (US$ Mn)
5.3. Global Cardiovascular Market Revenue, 2013–2023 (US$ Mn)
5.4. Global Arthritis Market Revenue, 2013–2023 (US$ Mn)
5.5. Global Neurological Market Revenue, 2013–2023 (US$ Mn)
5.6. Global Cancer Market Revenue, 2013–2023 (US$ Mn)
5.7. Global Osteoporosis Market Revenue, 2013–2023 (US$ Mn)
5.8. Global Respiratory Market Revenue, 2013–2023 (US$ Mn)
5.9. Global Others Market Revenue, 2013–2023 (US$ Mn)

6.Market Segmentation – By Geography
6.1. Introduction
6.2. Global Geriatric Medicines Market Revenue, by Geography, 2013–2023 (US$ Mn)
6.3. North America Geriatric Medicines Market Revenue, by Country, 2013–2023 (US$ Mn)
6.4. Europe Geriatric Medicines Market Revenue, by Country, 2013–2023 (US$ Mn)
6.5. Asia Pacific Geriatric Medicines Market Revenue, by Country, 2013–2023 (US$ Mn)
6.6. Latin America Geriatric Medicines Market Revenue, by Country, 2013–2023 (US$ Mn)
6.7. MEA Geriatric Medicines Market Revenue, by Country, 2013–2023,0020(US$ Mn)

7. Recommendations

8. Company Profiles
8.1. Abbott Laboratories, Inc.
8.2. AstraZeneca plc
8.3. Boehringer Ingelheim GmbH
8.4. Bristol-Myers Squibb Company
8.5. Eli Lilly and Company
8.6. GlaxoSmithKline Plc.
8.7. Merck & Company Inc.
8.8. Novartis AG
8.9. Pfizer, Inc.
8.10. Sanofi S.A